Updated on 9 October 2026
Custom antibodies
Marketing Team Leader at TAKIS SRL
rome, Italy
About
Takis’ custom monoclonal antibody platform utilizes DNA electroporation to immunize animals and hybridoma technology to generate the desired mouse monoclonal antibodies:
-
There is no need for antigen synthesis or expression.
-
Appropriate molecular engineering techniques are applied, including codon optimization, the use of a secretory leader sequence, and fusion with immunoenhancing moieties.
-
The antigen is expressed endogenously by muscle and antigen-presenting cells, leading to the induction of conformational antibodies.
-
The combination with immunomodulators further increases the probability of success.
-
Induction of conformational antibodies
Organisation
Similar opportunities
Investment
iRASP - a novel platform to design efficacious cancer targeted immunotherapies
- Pre-seed funding | Idea validation
- Seed funding | Get business started
Giorgia Moschetti
IP & Technology Transfer Specialist at Istituto Europeo di Oncologia (IEO)
Milan, Italy
Investment
NovaRNA - InNOVAtive approach to optimize untraslated regions for next-generation mRNA vaccines.
- Pre-seed funding | Idea validation
- Seed funding | Get business started
Giorgia Moschetti
IP & Technology Transfer Specialist at Istituto Europeo di Oncologia (IEO)
Milan, Italy
Investment
Searching for investors: Start Up constitution
Raonì Savaris
Scientist and BD at Gem Forlab srl
Caluso, Italy